. In the literature, EVs from Grampositive bacteria and from mycobacteria are usually called membrane vesi cles; for clarity, we refer to all extracellular vesicles as EVs, including those that have elsewhere been referred to as membrane vesicles. The existence of EVs across all three domains of the tree of life suggests that vesicular transport is a universal phenomenon.
Bacterial EVs were first reported in Escherichia coli in the 1960s, and the presence of fungal EVs was first proposed in 1973 . The existence of EVs produced by Grampositive bacteria was not men tioned in the literature until 1990 (REF. 19 ). In recent decades, research into EVs from Gramnegative bac teria increased substantially, but there was little to no EVrelated research with Grampositive bacte ria, mycobacteria or fungi. EVs from Gramnegative bacteria originate from the outer membrane and are thus usually referred to as outermembrane vesicles (OMVs) 20 
. OMVs carry varied cargo, including virulence factors, adhesins, DNA, RNA, communication compounds, toxins, immunomodulatory factors and nutrientscavenging factors. OMVs have been associated with cytotoxicity, the invasion of host cells, membrane fusion, the production of biofilms, and the transfer of viruses, DNA, receptors and antibioticresistance pro teins [21] [22] [23] [24] . These OMVs can therefore play a major part in microbial pathogenesis, and vesicles from Gram negative microorganisms have recently been developed into therapeutic vaccines 25 . Historically, the lack of interest in EVs in Gram positive bacteria, mycobacteria and fungi relative to those in Gramnegative bacteria has primarily been due to the inference that the thick cell wall of Grampositive bacteria, mycobacteria and fungi precluded their exist ence. OMVs from Gramnegative bacteria are released from the outer membrane by a pinchingoff process, encapsulating components from the periplasmic space 21, [26] [27] [28] [29] [30] [31] (FIG. 1a) , and there is presumably no physical barrier to the release of these OMVs to the extracellular space. By contrast, Grampositive bacteria lack an outer membrane but have a thick peptidoglycan cell wall out side of the cell membrane 32 (FIG. 1b) . In mycobacteria, peptidoglycan is covalently attached to arabinogalactan, which in turn is attached to mycolic acids. The upper segment of this cell wall associates with free lipids and is surrounded by an outermost capsule composed of polysaccharides, proteins and lipids 33 (FIG. 1c) . The archi tecture of Grampositive bacteria and mycobacteria is analogous to that of fungi, which also have a thick wall outside of the cellular membrane. The fungal cell wall consists of semistriated layers of chitin, βglucans
Virulence factors
Products that are important for infection by and survival of a pathogen. These factors can include adhesins, DNA, toxins and other molecules.
Biofilms
Surface-dwelling bacterial cultures that are highly resistant to disruption and removal. Biofilms can consist of a single species or a community of multiple microorganisms.
Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi Multivesicular bodies (MVBs) . A subset of endosomes that contain membrane-bound intraluminal vesicles that originate by budding into the MVB. Typically, MVBs fuse with the cell membrane to release the intraluminal vesicles into the extracellular space.
B-band lipopolysaccharide
(B-band LPS). LPS that is highly charged at neutral pH owing to the presence of a large number of phosphate groups and long O side chains, in contrast to A-band LPS.
and mannoproteins (also known as mannans) 34 
(FIG. 1d).
Some fungi also contain melanin in their walls, although whether these molecules are permanent or transitory is unknown 35 . The presence of these thick cell walls hin dered the search for EVs owing to the assumption that membranederived vesicles could not escape such large barriers.
In 2007, EVs were isolated and characterized from biofilms of Mycobacterium ulcerans and from the fun gal pathogen Cryptococcus neoformans, setting the stage for the study of vesiculogenesis in fungi, mycobacteria and Grampositive bacteria 36, 37 . Several studies have now purified EVs from cultured supernatants of cellwalled microorganisms, using physical separation protocols 38
. In this Review, we discuss those cellwalled microorganisms that have been found to produce EVs, the physiological properties of these EVs and hypotheses on the mechanisms of vesiculogenesis, and we outline the outstanding questions that are most pressing for the field to address.
Evidence for extracellular vesicles
In Grampositive bacteria, mycobacteria and fungi, pro teins secreted via specific pathways are important for celltocell communication, killing of competitors, nutri ent acquisition, detoxification of the external milieu and virulence [39] [40] [41] . However, surveys of the secretome often identify proteins lacking export signals or proteins other wise predicted to be cell associated, and why this should be the case has remained an enigma. In the Gram positive bacterium Bacillus subtilis, as many as half of those proteins observed to be secreted had not been predicted to be released into the extracellular space 39, 42 . In mycobacteria, mass spectrometry analysis of the cul ture filtrate showed that 25% of secreted proteins do not contain a secretion signal, and 10-30% of the fungal secretome does not have a predicted secretion signal [43] [44] [45] . In 1990, vesiclelike blebs were reported on the surface of Bacillus spp. but were not investigated further 19 . It was first hypothesized that fungi release EVs outside their cell membrane in the early 1970s, when freezeetching electron microscopy studies of the opportunistic pathogen C. neoformans revealed structures located between the cell wall and plasma membrane. These structures, termed 'paramural bod ies' , resembled multi vesicular bodies (MVBs) fusing with the plasma membrane to release intraluminal vesicles into the extracellular space. The authors speculated that paramural bodies "play a role in secreting cytoplasmic vesicles" analogous to that of MVBs 18 . However, the pos sibility that these vesicles would transverse the cell wall to reach the extracellular space does not appear to have been considered. Fungal EV production by membrane blebbing was again suggested by transmission electron microscopy (TEM) and scanning electron microscopy (SEM) of Candida albicans in 1990 (REF. 46 ). These results were recently confirmed in three different strains of C. albicans, including clinical isolates 47 . Despite this growing body of data suggesting that vesicles could reach the extracellular milieu through the cell wall, the notion remained overlooked because the structure of the cell wall was still thought to be too rigid to be per meable to large structures such as EVs. Aside from the question of how EVs traverse the thick cell wall, these studies also raised the question of why organisms invest in a secretion mechanism that has a high energy cost. In addition to vesicular secretion, these organisms have canonical secretion systems -such as the endoplas mic reticulum-Golgi secretion pathway in fungi and the SecA or Tat secretion systems in bacteria -that secrete proteins containing predicted secretion signals. Of note, most of the genetic machinery involved in these canonical secretion systems has been elucidated. Conversely, very few genes have been shown to influ ence vesiculation in fungi or bacteria. To date, there are no studies comparing the contribution of EV produc tion and other secretion systems to the overall energy cost of cellular export.
Extracellular vesicles from Gram-positive bacteria.
In 2009, the protein composition of EVs produced by the Grampositive bacterium Staphylococcus aureus was characterized by mass spectrometry. This large scale study of EVs from a Grampositive organism reported their size as ~20-100 nm in diameter, which is comparable to EVs isolated from Gramnegative bacteria, and found that their contents included a variety of proteins that are important for survival and virulence 3 . Subsequently, EVs have been isolated from planktonic and biofilm cultures for a variety of Gram positive bacteria, as well as, more rarely, in in vitro and in vivo studies [3] [4] [5] [6] [7] [8] [9] [10] [11] [48] [49] [50] [51] [52] [53] . Streptomyces coelicolor EVs were isolated from droplets that grew on sporulating lawns of the bacterium 48 , and EVs in the process of release from Listeria monocytogenes cells have been visual ized with TEM
. Ultrastructural characterization (including TEM, negativestaining TEM and SEM) of EV preparations from B. subtilis revealed a heteroge neous EV population and correlated EV diameter with electron density, suggesting the existence of a potential Box 1 | Outer membrane vesicles in Gram-negative bacteria Extracellular vesicles produced by Gram-negative bacteria are derived from the outer membrane, a signature feature of Gram-negative bacteria, and are thus referred to as outer-membrane vesicles (OMVs). Various hypotheses have been proposed as to how OMVs are formed and released from the cell. OMVs may be produced during cell wall turnover, in which OMV blebbing would be a result of increased turgor pressure from cell wall components such as peptidoglycan, or they may form when repulsion between charged B-band lipopolysaccharide (LPS) molecules results in membrane budding 31, [105] [106] [107] . In Pseudomonas aeruginosa, the quorum sensing molecule Pseudomonas quinolone signal (PQS) may induce OMV formation. PQS interacts with LPS in the outer membrane, causing the outer leaflet of the membrane to expand faster than the inner leaflet, thus forming a membrane bleb; this mechanism is known as the bilayer-couple model 30, 31 . OMVs act as vehicles for the secretion of many virulence factors, including Shiga toxin from Escherichia coli and Cif toxin from P. aeruginosa 108, 109 . OMVs not only act as a vehicle for secretion, but also concentrate hydrophobic molecules and protect the vesicle contents from extracellular proteases. Purified OMVs can be cytotoxic and deliver virulence factors in a concentrated manner directly to the host cell by fusing with cholesterol microdomains on the host cell membrane 
Mannoproteins
cargosorting method based on EV size 10 . Interestingly, EVs produced by Staphylococcus spp., Streptococcus pneumoniae and L. monocytogenes seem to be much smaller than EVs from other Grampositive bacteria studied, with the caveat that definitive conclusions of EV diameter would require comparisons using the same methodology 3, 8, 9 . EVs from these organisms range from 20 nm to 150 nm in diameter, whereas Bacillus spp., Clostridium perfringens and S. coelicolor EVs range from 20 nm to 400 nm in diameter 4, 10, 11, 48 . This variability in the size of EVs suggests that although vesiculogenesis may be a universal phenomenon, organisms synthesize and regulate EVs in different ways.
Extracellular vesicles from mycobacteria. Mycobacteria also release EVs as a means to secrete a large, com plex group of proteins and lipids into the extracellular milieu 6, 37, 38, 50, 52, 54 . Vesiclelike blebs were observed on the surface of mycobacterial cells by TEM and SEM and were similar in size to purified EVs, consistent with the notion that these structures represent EVs in the process of release 6 
. This study extended the phenome non of EV production to the more medically important strains of mycobacteria, Mycobacterium tuberculosis and Mycobacterium bovis bacille Calmette-Guérin (BCG) 6 . The size distribution of EVs isolated from M. bovis BCG was similar to that of OMVs from Gramnegative The outer membrane contains lipopolysaccharides on its outer leaflet and facilitates non-vesicle-mediated transport through channels such as porins or specialized transporters. It is thought that vesicles from these organisms are produced by the pinching off of the outer membrane, resulting in outer-membrane vesicles (OMVs) 26, [28] [29] [30] . The lack of an outer membrane, as well as the presence of a thick cell wall, in Gram-positive bacteria, mycobacteria and fungi led to a long-standing belief that these organisms did not produce extracellular vesicles. b | Gram-positive bacteria have a single lipid membrane surrounded by a cell wall composed of a thick layer of peptidoglycan and lipoteichoic acid, which is anchored to the cell membrane by diacylglycerol 32 . c | Cell walls of mycobacteria consist of thin layers of peptidoglycan and arabinogalactan, and a thick layer of mycolic acids 33 . Glycolipids and porins are also found in these cell walls, as is lipoarabinomannan, which is anchored to the cell membrane by diacylglycerol. This cell wall surrounds a single lipid membrane. d | A single plasma membrane is also present in fungi, surrounded by a cell wall consisting of various layers of the polysaccharides chitin, β-glucan and mannan (in the form of mannoproteins) 34 . 
. Fungal production of EVs requires living cells, as neither heattreated nor sodium azidekilled cultures produced EVs 36, 55 . Although there is evidence that cellular apoptosis can be accompa nied by the production of EVs 56 , the time at which fun gal EVs were analysed corresponded to the logarithmic phase of growth, when presumably no apoptosis occurs.
Evidence that suggests a role for EVs in pathogen esis came from the identification of virulence factors as part of the EV cargo. However, virulence cannot be the sole function of EVs, as the nonpathogenic model yeast Saccharomyces cerevisiae produces EVs with 400 cargo proteins 57 . It is interesting that despite all the work carried out on secretion in yeast over several decades, EVs were characterized in the opportunistic pathogen C. neofor mans before they were found in the yeast model organism S. cerevisiae. EVs have now been described in many fungi, and their EV proteomes have revealed a wide array of protein cargoes, including proteins that have a role in cell metabolism, signal transduction and virulence, as well as structural scaffold proteins and nuclear proteins 2, 12, 57, 58 .
Release of extracellular vesicles
How are EVs released from the cell wall? Little is known about this important process, but support for three non mutually exclusive hypotheses exists in the literature (FIG. 2) . EVs may be forced through the wall by turgor pressure after release from the plasma membrane. In this case, EV release may be regulated by cell wall pore size or thickness 1, 59 (FIG. 2a) . Alternatively, or in addition, cell wallmodifying enzymes released with EVs may facili tate a loosening of the wall to enable EV release (FIG. 2b) ; such enzymes have been found in both fungal and bacterial EV purifications 2, 3 . Finally, EVs might transit through channels, and it is possible that the deforma tion of EVs allows their passage through pores that are narrower than the measured EV diameter; EVs might be guided to the channels by tubulin, which has been found in many fungal proteomics preparations, or other molecular cables 1, 59 (FIG. 2c) . The higher permeability of cell walls in live fungal cells compared with those in dead cells might determine the size of EV that can be trans ported through the cell wall 60 . In addition, these differ ences between live and dead fungal cells may explain the lack of EV release by dead fungal cells.
Data are mixed for support of the above hypotheses regarding EV transit through the fungal cell wall. The fungal cell wall is a dynamic organelle that surrounds the plasma membrane and is constantly remodelled according to cell cycle, metabolic and environmental conditions 35, [61] [62] [63] . Pore size in the wellcharacterized
Box 2 | Isolation of extracellular vesicles
The standard protocol for purifying extracellular vesicles (EVs) derived from Gram-positive bacteria, mycobacteria and fungi uses a series of steps to physically separate EVs from cellular cultures (see the figure, part a). A culture is grown for a specified period of time. Cells and debris are removed by centrifugation and subsequent filtration through a 0.22 μm filter. Cell-free supernatant is then concentrated to small volumes with a 100 kDa filter membrane. Finally, the concentrated supernatant is spun at 100,000 g to pellet the EVs while the soluble proteins remain in the supernatant. Alternatively, transmission electron micrography (TEM) or scanning electron microscopy (SEM) can be used to study non-purified EVs. For example, TEM has been used to image an EV in the process of release from a Listeria monocytogenes cell (see the figure, part b, arrow) and SEM has been used to image a putative EV protrusion on the surface of a Mycobacterium bovis bacille Calmette-Guérin Pasteur cell (see the figure, part c, arrow) .
In Cryptococcus neoformans, TEM has produced micrographs of EVs inside the cell wall (see the figure, part d, arrows) and of isolated EVs (see the figure, part e, three examples are indicated with arrows). All scale bars represent 100 nm. S. cerevisiae cell wall varies from 50 nm to 500 nm and can increase to 400 nm under stress conditions 64 . This pore size is comparable to EV diameter, and the pore therefore represents a potential channel for EVs to trav erse the cell wall in this species. In C. neoformans, the induction of melanization causes a decrease in cell wall pore size and is associated with the accumulation of vesiclelike structures between the plasma membrane and cell wall, which can be interpreted as a reduction in the porosity needed for EV export 65, 66 . It is conceivable that remodelling of the cell wall to facilitate EV transit occurs in response to a secretion signal; alternatively, EV release may occur at natural 'break points' of the cell wall, such as at areas that undergo thinning during daughter cell budding 67 . EVs may stimulate remodelling by including wallremodelling enzymes as their cargo: βglucosidases and endochitinases have been identified in proteo mic screens of both basidiomycetes and ascomycetes, raising the possibility that their enzymatic activities contribute to EV transit through the cell wall in these organisms 2, 36, 57 . Such a mechanism may be widespread, as EVs from the Grampositive bacterium S. aureus carry peptidoglycandegrading enzymes, such as Sle1, that can manipulate the thick Grampositive peptidogly can cell wall 3 . One possible explanation for the broad range of sizes of fungal EVs is that cytosolderived EVs could swell when they are exposed to the lower osmo lality of the extracellular environment (compared with that of the cytoplasm), causing them to burst and subse quently reseal. However, we lack definitive information on how EVs cross the cell wall of Grampositive bacteria, mycobacteria and fungi, and this is an important area for further investigation.
In Gramnegative bacteria, genes affecting OMV production have been identified in E. coli using a screen for known OMV components and lipids 68 . Although vesiculogenesis in Gramnegative bacteria has been studied intensively, an OMVnull mutant has never been isolated; this raises the possibility that OMV for mation is only partially under genetic regulation and is driven by physical and biochemical processes that are not attributable to single genes. Data about the genetic regulation of vesiculogenesis in Grampositive bacteria, mycobacteria and fungi are lacking, with the exception of data concerning L. monocytogenes sigB (encoding RNA polymerase sigma factor σ B ) and M. tubercu losis vesiculogenesis and immune response regulator (virR; also known as rv0431), the roles of which in vesiculo genesis offer insight into the mechanism of this process 8, 50 . Evidence suggests that the transcription factor σ B regulates some aspects of vesiculogenesis in L. monocy togenes 8 . σ B regulates genes required for survival under cellular stress, as well as the expression of internalin B (InlB), which is important for bacterial invasion, and positive regulatory factor A (PrfA), which regulates the biosynthesis of the haemolytic toxin listeriolysin O (LLO) 69, 70 . EVs isolated from a wildtype strain con tained three times as much InlB as EVs from a ΔsigB mutant strain, whereas the expression of LLO associated with EVs remained the same in the two strains, indicat ing that σ B can contribute to EV cargo regulation 8 . Fewer EVs were recovered from the ΔsigB mutant than from the wildtype strain, as measured by protein content. Although the quantification of EVs is often determined based on protein concentration, this method does not take into account the possibility that the same number of EVs could be produced, but each could be associated with less protein than in the wild type. EVs from the ΔsigB mutant strain also appeared deformed compared with EVs from a wildtype strain In a recent study, virR was identified as a regulator of immune modulation and EV formation in mycobac teria 50 . Disruption of virR augments cytokine produc tion by mouse and human macrophages in response to the bacterium, and results in an attenuated phenotype in macrophages and mice 50 . However, virR deletion mutants have no growth defect in broth culture, which suggests a role for virR in M. tuberculosis virulence. virR seems to control the release of immunomodulatory fac tors, such as the lipoprotein LpqH, via EVs, as there is no evidence that virR deficiency globally enhances the nonEV secretory pathways mediated by SecA2 and Tat. However, only a limited number of proteins that are transported via the nonEV secretory pathway were tested (6 kDa early secretory antigenic target (Esat6), Ag85b, αcrystallin (HspX; also known as Acr), catalaseperoxidase (KatG; also known as CP) and βlactamase (BlaC)), and it is possible that the virR mutation affects secretion of other nonEV substrates 50 . VirR is a cyto plasmic protein with a highly hydrophobic region, which suggests that it binds to the inner face of the cell membrane or to a protein with a hydrophobic surface. Coimmunoprecipitation studies led to the identification . b | Cell wall-modifying enzymes released with EVs may 'loosen' the wall and increase pore size to facilitate EV release. Preparations of EVs from both fungi and Gram-positive bacteria include cell wall-modifying enzymes 2, 3 . c | Protein channels or structural cables may guide EVs to the extracellular environment. Proteomic data show that many fungal EV preparations contain tubulin and/or actin, which are components of structural cables (not shown) 1, 59 . . As all of the VirR interacting partners are predicted membrane proteins, VirR might form a higherorder complex with LpqH, Rv1488 and Rv0383c that regulates EV forma tion at the membrane. Notably, the carboxyl terminus of VirR has a domain annotated as cell enveloperelated or LytR family transcriptional regulator; as these regulators have important roles in peptidoglycan formation, cell wall formation and stress tolerance, these data suggest that VirR mediates similar functions.
It is noteworthy that progress in this field has been slowed by continuing debates as to whether the observed EVs were artefacts of lipid selfassembly in solution or were released from dead cells. The absence of null mutants fed into this controversy, because of the precedence of using null mutants as proof of existence for certain processes. However, the multiple reports that an active metabolism is required for EV produc tion and that killed cells do not generate EVs weigh heavily against the argument that the observed EVs were not physiological. Taken together, the inability to recover null mutants for EV production and the ubiq uity of EVs suggest that vesiculogenesis is an integral function of microbial cells and not under the control of single genes.
Cargo and functions of extracellular vesicles
EVs can carry a wide range of intraluminal cargo, including nucleic acids, polysaccharides and proteins (FIG. 3a) . Although early studies reported that EVs from Grampositive bacteria did not contain DNA, EVs from Streptococcus mutans and C. perfringens were sub sequently reported to contain extracellular DNA (eDNA) and chromosomal DNA, respectively 11, 19, 53 . In C. per fringens, genes encoding αtoxin (also known as PLC) and the toxin perfringolysin O (PFO) were amplified from purified EVs. As this DNA was recovered from EV preparations treated with DNase I, it seems that nucleic acids in EVs are protected from exonucleases 11 . Recently, fungal EVs were shown to contain a variety of RNAs, including microRNA, mRNA and rRNA 71, 72 . EVs isolated from the nonpathogenic species B. subtilis are enriched in lipoproteins and contain proteins important for survival, such as Sunl (also known as YolF), which confers selfimmunity to sublancin, an antibiotic pro duced by the bacterium 10, 73 . Antibiotics have also been associated with EVs, including actinorhodin, which was identified in EVcontaining exudates that grow on the surface of S. coelicolor lawns; actinorhodin was purified along with many other proteins, such as bacterioferritin binding proteins and TerB and TerD proteins, which are involved in iron metabolism and tellurite resistance, respectively. However, the proteomics was performed on fractions from the entire S. coelicolor exudate drop let rather than on purified EVs, so conclusions about EVassociated cargo must await further studies 48 . After TLR binding, the nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signalling pathways are activated, leading to cytokine production. However, a prolonged activation of these pathways can lead to the repression of genes involved in antigen presentation. Bacillus anthracis concentrates anthrax toxins into EVs that are thought to deliver the intraluminal contents directly into the host cell cytoplasm by fusing with cholesterol microdomains in the host cell membrane. b | Subpopulations of EVs might be retained in the microbial cell wall to deliver materials that are required for cell wall synthesis and maintenance. In melanizing fungi, laccase is an important enzyme involved in the synthesis of the protective melanin polymer contained in the cell wall. Laccase has been identified in EVs produced by these fungi, and it has been proposed that these laccase-containing EVs are retained in the cell wall to enable in situ melanin synthesis. 
Penicillin-binding proteins
Proteins that are essential for bacterial cell wall biogenesis and also have the capacity to bind to penicillin.
Glucuronoxylomannan (GXM).
A polysaccharide that is produced by the pathogenic fungus Cryptococcus neoformans and is a major component of the cellular capsule.
Cytolysin
A toxin with the ability to lyse cells.
Mycolactone
A macrolide toxin that is produced by a group of mycobacteria and causes Buruli ulcers in humans. It is required for virulence, is cytotoxic and blocks the translocation of immune proteins into the endoplasmic reticulum as a mechanism of immunosuppression.
Cholesterol microdomains
Lipid domains in the cellular lipid bilayer that are enriched in cholesterol. 
T helper 2 cell

T H 1 cell
A subset of CD4 + effector T cells that is required for host defence against intracellular viral and bacterial pathogens. T H 1 cells secrete cytokines such as interferon-γ (IFNγ), interleukin-2 (IL-2), IL-10 and lymphotoxin, promoting macrophage activation, nitric oxide production and cytotoxic T lymphocyte proliferation.
Virulence factors associated with extracellular vesicles.
EVs from cellwalled organisms are associated with various virulence factors that are important for drug resistance, immune system evasion, host cell invasion and pathogenesis. EV pellets purified from S. aureus are enriched in penicillin-binding proteins, which naturally bind to βlactam antibiotics, and the membraneassoci ated global regulator MsrR, which has been implicated in methicillin resistance 3, 5, 74 . S. aureus EVs also contain superantigens, lipase and immunoglobulin Gbinding proteins (such as protein A), which help the bacterium to evade the immune system; staphopain A, a protein that may be important for cellular invasion 3, 51, 75 ; and αhaemolysins, which form cytotoxic pores and may induce apoptosis.
Proteomic surveys of EVs from C. neoformans, Histoplasma capsulatum and Paracoccidioides brasilien sis have identified virulenceassociated protein cargo, including heatshock proteins, superoxide dismutase and catalases; more sensitive biochemical assays with C. neoformans EVs identified cryptococcal laccase, an enzyme that is important for the synthesis of the cell wall melanin polymer that protects fungi from the immune response and radiation 1, 2, [76] [77] [78] [79] . Fungal EV cargo also includes glycoconjugates, such as the highly immuno genic αgalactosyl epitope found on the P. brasiliensis cell wall, and glucuronoxylomannan (GXM), a major capsule polysaccharide component in C. neoformans 36, 58 . The incorporation of these cell wallassociated enzymes and glycoconjugates suggests that one function of EVs is to deliver cell wall building materials to the exterior of the wall.
EVs might also act as vehicles for interspecies com munication and the transfer of DNA or proteins con ferring antibiotic resistance. For example, S. aureus EVs deliver the resistance protein βlactamase (BlaZ) to ampicillinsensitive Gramnegative and Grampositive bacteria, which is consistent with a role for EVs in the spread of antibiotic resistance 3, 5, 7 .
Toxins associated with extracellular vesicles. Many tox ins produced by microbial organisms are required for pathogenesis. Some of these toxins form pores in host membranes, resulting in membrane disruption or the entry of other virulence factors and leading to cyto toxicity, the suppression of immune responses or the initiation of apoptosis. For intracellular pathogens, tox ins have been implicated in invasion and escape from host cells.
Toxins produced by Grampositive bacteria have been associated with EVs, and in many cases, toxin containing EVs are biologically active. As mentioned above, EVs purified from L. monocytogenes contain the virulence factors InlB and LLO 8 ; both of these pro teins are important for cellular invasion and escape from host vacuoles 80, 81 , although the role of LLO and InlBassociated EVs in pathogenesis still needs to be elucidated. In S. pneumoniae, EVs contain the toxin pneumolysin (Ply), a poreforming cytolysin that lacks an export signal and is an important virulence factor for colonization and pathogenesis 9, 82 . Cytotoxins lacking an export signal, such as the poreforming toxin ClyA (also known as HlyE), have also been identified in OMVs from E. coli, suggesting that toxins are also exported by vesicle transport in Gramnegative bacteria. Vesicle mediated transport explains how Ply, ClyA and other cytotoxins that do not encode an export signal can be exported from the cell to the extracellular space 83 . In the anthraxproducing bacterium Bacillus anthra cis, the components of anthrax toxin (lethal factor (LF), oedema factor (EF; also known as Cya) and protective antigen (PA)), as well as the cholesteroldependent cyto lysin anthrolysin (ALO), are found in the EV pellet of the bacterial cell culture after centrifugation, but not in the supernatant, suggesting that the overwhelming majority of toxin released from cells is encapsulated in EVs 4,84,85 (FIG. 3a) . By contrast, two major toxins of C. perfringens -necrotic enteritis toxin B (NetB), which forms mem brane pores, and haemolytic αtoxin -were found only in supernatants and not in EV pellets, suggesting that not all toxins are secreted via EVs 11, 86, 87 . In many cases, intact EVs from Grampositive bac teria are more cytotoxic to cells than disrupted EVs or purified toxin alone. Intact EVs but not lysed EVs from S. aureus are cytotoxic to cells, and purified M. ulcer ans EVs containing the toxin mycolactone are more cytotoxic to cells than purified toxin alone, providing further evidence that the capacity of toxinassociated EVs to mediate damage is an integral part of bacterial pathogenesis 37, 51 . Fluorescently labelled mycolactone accumulates in the cytosol of host cells and does not compete with unlabelled mycolactone, suggesting that the toxin passively diffuses through the cell membrane rather than utilizing a membrane receptor 88 . This cyto solic location and action could be a result of EV-mem brane fusion and the subsequent release of mycolactone into the host cytoplasm. Additional evidence that EVs fuse with host cell membranes comes from the delivery of the S. aureus toxins protein A and αtoxin into host cells via cholesterol microdomains 5, 51 (FIG. 3a) .
Host response to microbial extracellular vesicles. EVs can directly influence the immune system to suppress antifungal responses. Mouse macrophages stimulated with C. neoformans EVs secrete nitric oxide and the cytokines tumour necrosis factor (TNF), transforming growth factorβ (TGFβ) and interleukin10 (IL10) 89 . EVs containing GXM, a known immunomodulator, skew the response profile towards a T helper 2 cell (T H 2 cell) bias, with higher concentrations of TGFβ and IL10 than TNF 90, 91 . However, EVs from an acapsular mutant do not incorporate GXM as cargo and skew the host response toward a T H 1 cell profile, with increased TNF and nitric oxide production 91 . EVs are biologically active and can cause disease without the presence of live cells. Purified EVs from S. aureus upregulated proinflammatory mediators in vitro and in vivo, and elicited a T H 17type response and increased production of IgE, causing atopic dermatitis like inflammation on tapestripped mouse skin 49 . C. per fringens EVs were not toxic to macrophages, probably owing to the absence of PFO toxin in these EVs, but did
Granulomatous inflammation
The aggregation of mononuclear inflammatory cells, which can be accompanied by the infiltration of other leukocytes or by necrosis.
Koch phenomenon
A rapid inflammatory response that develops to a reinfection with Mycobacterium tuberculosis and that is marked by necrotic lesions. The response is caused by hypersensitivity to products of the tubercle bacillus.
elicit the production of inflammatory cytokines such as TNF, IL6 and granulocyte colonystimulating factor (GCSF) in in vitro experiments 11 . Proteomic analysis of M. tuberculosis and M. bovis BCG EVs showed that they were enriched in proteins associated with virulence, including the lipoproteins LpqH, LppX, LprA and PstS1, which are a wellknown group of Tolllike receptor 2 (TLR2) ligands that inter fere with the antigen presentation process in dendritic cells and macrophages 6, 92 (FIG. 3a) . Of note, EVs from the nonpathogenic strain Mycobacterium smegmatis showed no enrichment in lipoproteins. As expected from their protein and lipid cargo, mycobacterial EVs elicit a pro found TLR2dependent inflammatory response in vitro and in vivo (FIG. 3a) . Remarkably, when EVtreated mice were challenged with M. tuberculosis H37Rv, they showed an increase in granulomatous inflammation in the lungs, as well as an increase in the bacterial loads in both lungs and the spleen 6 . Mice immunized with EVs often elicit an immune response specific to EV components. Sera from mice immunized with B. anthracis and S. pneumoniae EVs react with toxin components and produce EVspecific antibodies, respectively 4, 9 . Interestingly, human serum produces a stronger western blot signal when reacting to S. pneumoniae EV fractions than when reacting to whole bacterial cells, indicating that EVs might have a vital role in the host-pathogen interaction 9 . In a combined mouse in vivo and human in vitro study, EV adminis tration before C. neoformans challenge resulted in an increase in cryptococcal crossing of the blood-brain barrier and an accumulation of cryptococcusderived EVs in fungal brain lesions, suggesting a new role for EVs in fungal pathogenesis 93 . The incorporation of cell wallassociated fungal antigens such as laccase and αgalactosylcontaining glycoconjugates into EVs sug gests that EVs distract the immune system by deliver ing infectionrelated substances to sites distal to the site of infection, thus acting as molecular decoys that draw immune cells away 36, 58 . Some of the polar lipids associated with mycobac terial EVs, such as phosphatidylinositol dimannoside (PIM 2 ) and phosphatidylinositol hexamannoside (PIM 6 ), are ligands of TLR2 (REF. 94 ). In mycobacteria, EVs induced a TLR2dependent inflammatory response in macrophages in both in vitro and in vivo infections and after direct administration in mouse lungs 6 . The inflam matory response to mycobacterial EVs was detrimental in mice when combined with an aerosol challenge using a virulent strain of M. tuberculosis, producing a 'Koch phenomenon' that suggests a role for EVs in M. tubercu losis pathogenesis. Remarkably, no increase in patho genesis was observed when aerosolized M. tuberculosis infection was combined with the infusion of M. smeg matis EVs, suggesting that specific components of the M. tuberculosis EVs were responsible for eliciting the deleterious immune response 6 . EVs not only elicit an immune response when administered to mice, but in many cases also protect against disease. Mice immunized with purified EVs from B. anthracis, S. pneumoniae and M. tuberculosis lived longer than control mice and, in some cases, were protected from disease, indicating the potential for the utilization of EVs in vaccine development 4, 9, 54 . The injection of C. albicans EVs into the model invertebrate Galleria mellonella before infection with the yeast itself increased host survival, suggesting that some fungal EVs also elicit protective host responses 47 . EVs from C. per fringens, however, were not protective in mice, possibly because the major toxins NetB and αtoxin do not seem to form part of the EV cargo 11 . Extracellular vesicles associated with biofilms. Biofilms are thought to be the primary state in which many microbial organisms exist in the environment, and bio film formation poses major problems in clinical settings. Biofilms protect microbial cultures from disruption, from removal from surfaces and from antimicrobial molecules, and thus are the source of many nosocomial infections 95 . The role of EVs in biofilm formation has been investigated in B. subtilis, M. ulcerans, S. mutans and C. neoformans 10, 37, 53, 96 . In B. subtilis biofilms, EVs were present in the matrix and were visualized pro truding from biofilmembedded cells 10 . In M. ulcer ans biofilms, EVs were restricted to the extracellular matrix surrounding the outer portion of the cellular community, and were not distributed throughout the entire intricate biofilm structure 37 . eDNA, which acts as a structural component of biofilms, was associated with EVs isolated from S. mutans planktonic cultures. The presence of eDNAcontaining EVs in planktonic cultures suggests that EVs play a part in biofilm pro duction, bacterial colonization and subsequent resist ance to removal techniques 53 . Staphylococcus spp. are a leading cause of biofilmrelated nosocomial infections, and although data have yet to be published for biofilms formed by S. aureus, it is likely that EVs are an important factor in such biofilm matrices as well. L. monocytogenes EVs isolated from planktonic cultures contained protein components of biofilms, but EVs have yet to be isolated directly from biofilms for this species 8 . Extracellular vesicles and fungal melanization. Although many EVs contain virulence factors or enzymes des tined for delivery outside the cell, a certain proportion of EVs may be deliberately retained in the cell wall. Lipid analysis of P. brasiliensis shows that cell wall extracts and purified EVs have a similar composition, which may be indicative of EVs either taking up permanent residence in the cell wall or transiently passing through the wall to be released extracellularly 59 . Fungal EVs carry lac case, an enzyme traditionally associated with depositing melanin in the cell wall 97 . A subpopulation of laccase containing EVs may be directed for retention in the cell wall through an unknown molecular delivery system (FIG. 3b) . EV involvement in C. albicans melanization is supported by the description of rounded, electron dense blebs with EVlike dimensions budding from the melanized cell during cell wall melanization 98 . Future studies on cell wall transit will have to consider possible EV subpopulations destined for cell wall retention versus those destined for extracellular release. 
Lipidic nanovesicles
Nanoscale lipid-bilayer spheres or liposomes.
Outlook
There is now conclusive evidence from many labora tories that microorganisms with thick cell walls, such as Grampositive bacteria, mycobacteria and fungi, do produce EVs (comprehensive information on EV research can be found on the community web portal, EVpedia [99] [100] [101] [102] ). These vesicles are associated with impor tant virulence factors and have been shown to be bio logically active, causing host cell death, eliciting immune responses and, in some cases, conferring disease protec tion. Collectively, these findings directly implicate EVs in the pathogenesis of many infectious diseases. The exist ence of EVs produced by microorganisms with thick cell walls is now generally accepted, but their ability to cross the thick cell wall raises fascinating questions regarding the cellular mechanisms responsible for this phenom enon. As the EV field is young, many of these important questions remain unanswered. Although the study of EV production in Grampositive bacteria, mycobacteria and fungi has intensified, the mechanism of vesiculogenesis in these cellwalled organisms remains poorly under stood, and how the release of vesicular contents is regu lated is also an important question. Future work may elucidate the temporal control of the production and/or disruption of EVs
.
The study of vesiculogenesis in Gramnegative bacteria has already resulted in vaccines derived from detergentextracted OMVs (dOMVs), induced natural blebbing OMVs (nOMVs), OMV proteoliposomes and lipidic nanovesicles 25 . Vaccines from OMVs have been licensed for Neisseria meningitidis serogroup B, and OMV formulations against other Gramnegative bacte ria are currently being pursued 103, 104 . EVs isolated from pathogenic Grampositive bacteria, such as B. anthracis and S. pneumonia, and from pathogenic mycobacteria, such as M. tuberculosis, elicit an immune response that in some cases offers disease protection, and these find ings show that there is a potential for vaccines to be developed from EVs from Grampositive bacteria 4, 9, 38 . Although the genetic regulation of EV production, release and pathogenesis is an important topic, perhaps the most challenging unsolved question in the field is the mechanism by which EVs are able to traverse the Grampositive, mycobacterial and fungal cell walls. Current knowledge in the field is mainly limited to basic biological studies that characterize EVs but lack mecha nistic insights; however, these studies are an important foundation for future molecular and immunological research. As EV production is a phenomenon that affects all aspects of microbial physiology, ranging from biofilm formation to secretion and pathogenesis, we hope that this Review will stimulate more work on vesiculogenesis in microorganisms with thick cell walls and will encour age more investigators to look for EVs in their favourite Grampositive bacteria, mycobacteria and fungi.
Box 3 | Extracellular vesicle stability
Extracellular vesicles (EVs) act as a vehicle to concentrate the luminal contents and shield them from extracellular degradation; however, this shielding effect is not consistent with the finding that some EV contents, such as anthrax toxins, can interact with host cells and toxin-neutralizing antibodies. Therefore, the stability of EVs under various conditions is of great interest. EVs produced by Cryptococcus neoformans and Bacillus anthracis can be disrupted in vitro by serum albumin; this is the case even in the presence of protease inhibitors, which suggests that it is the albumin itself, rather than proteases released from the albumin, that is responsible for the disruption 55 . There is also evidence that serum disrupts Staphylococcus aureus EVs
51
. Serum-mediated lysis raises the question of whether it is the microorganism or the host that benefits from this active process, as EV disruption would release toxins but negate the delivery of toxic cargo in a concentrated manner.
Surfactin, the lipopeptide produced by Bacillus subtilis, is an antibiotic owing to its ability to act as a detergent [111] [112] [113] . Laboratory strains of B. subtilis harbouring a mutation in sfp, which encodes a phosphopantetheinyl transferase required for surfactin biosynthesis, cannot produce the lipopeptide 114, 115 . A large quantity of EVs can be recovered from these surfactin-null (sfp -) laboratory strains, which could serve as an efficient model for producing large quantities of EVs, but surfactin-producing (sfp + ) environmental strains synthesize very few recoverable EVs. Pure surfactin has the ability to disrupt EVs isolated from B. subtilis and B. anthracis 10 , as does spent cell-free media from sfp + strain cultures. This suggests that bacteria synthesize specific molecules to disrupt EVs and subsequently release their contents into the environment. Future work on the relationship between the temporal expression of surfactin and EVs will be an interesting pursuit. These data present a new mechanism for the direct disruption of EVs and a novel function for surfactin.
